NES
AVNS icon

New England Securities’s Avanos Medical AVNS Stock Holding History

New England Securities’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5K Buy
+116
New +$4.56K ﹤0.01% 1248

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

New England Securities's AVNS Position: Q4 2014 in Review

New England Securities opened a new position in Avanos Medical (AVNS) in Q4 2014: 116 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1248 among its holdings.

467 funds tracked by Wall St. Rank hold AVNS as of Q4 2014.

  • New England Securities held 116 shares of Avanos Medical worth $5K as of Q4 2014.
  • Avanos Medical was a new New England Securities position in Q4 2014.
  • Avanos Medical made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1248 holding.
  • 467 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.